<DOC>
	<DOCNO>NCT00261430</DOCNO>
	<brief_summary>The purpose study examine treatment practice adult schizophrenia patient doctor , assess patient outcome treat long-acting risperidone injection two-year period observation .</brief_summary>
	<brief_title>A 2-year Study Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone .</brief_title>
	<detailed_description>Controlled clinical trial treat schizophrenia often involve select patient common characteristic . It recognize schizophrenia much diverse clinical setting , physician 's prescribing practice may vary . The objective study examine treatment practice adult schizophrenic patient physician , assess patient outcome treat long-acting risperidone injection . This 2-year , prospective , multi-center , longitudinal , observational study adult schizophrenia . Physicians determine appropriate treatment patient , accord usual practice . Patients start treatment long-acting risperidone injection meeting study criterion may enroll study . Patients continue treatment accord usual care physician . Patients ask question baseline every three month period two year assess : efficacy medication , well patient functioning , use healthcare resource ( e.g. , emergency room visit , hospitalization ) patient work status , quality life patient satisfaction medicine . Safety monitor throughout study . A dose 25 , 37.5 50 mg risperidone , administer every 2 week intramuscular injection .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis schizophrenia longterm use antipsychotic medication take oral antipsychotic 4 week study stable respect disease symptoms medical condition female , use birth control . At risk self others use injectable antipsychotic within past 6 month , clozapine , investigational drug within 30 day consider resistant treatment pregnant breastfeeding use birth control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>acceptance</keyword>
	<keyword>motivational enhancement therapy</keyword>
	<keyword>long-acting risperidone</keyword>
	<keyword>intramuscular injection</keyword>
	<keyword>Treatment Guidebook</keyword>
	<keyword>GAIN Acceptance Approach</keyword>
</DOC>